Classys Proves Effectiveness and Safety of 'Alpha' Medical Device for Reducing Subcutaneous Fat... Published in SCI-Level Journal

Abdominal Subcutaneous Fat Reduction Rate 20~25%

Classys 'Alpha'

[Asia Economy Reporter Lee Gwan-ju] Classys announced on the 26th that the efficacy and safety of its fat reduction medical device 'ALPHA' have been proven through an international academic journal.

ALPHA is a medical device that reduces fat layers using cooling control technology. In this study, two treatments were performed at 4-week intervals on the abdomens of 25 subjects, including foreigners, using ALPHA. Ultrasound examinations confirmed a 20-25% reduction rate in abdominal subcutaneous fat.

The research team stated, "We confirmed that the reduction of abdominal subcutaneous fat was statistically significant up to 16 weeks after the first treatment," adding, "Most participants did not experience persistent pain or side effects, and there were no clinically significant changes in blood lipid levels or liver function tests."

This research paper was published in the SCI-level international academic journal 'Dermatologic Therapy.' A Classys official said, "Including this paper's publication, Classys now holds a total of 12 papers, comprising 4 preclinical and 8 clinical studies," and added, "We will enhance technological competitiveness by increasing the reliability and safety of medical devices through continuous research and clinical trials."

This content was produced with the assistance of AI translation services.